Loading...

Efficacy of third-line therapy using bevacizumab in a patient with metastatic colorectal cancer

Bevacizumab is currently approved in association with first- and second-line 5-fluorouracil–based chemotherapy regimens for patients with metastatic colorectal cancer. Few data about the usefulness of bevacizumab in third-line settings are available. We describe a patient refractory to folfiri and f...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Gaulin, J., Kotb, R., Turcotte, E., Berard, G., Sawan, B., Schmutz, G., Beauregard, P.
Format: Artigo
Sprog:Inglês
Udgivet: Multimed Inc. 2009
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2768516/
https://ncbi.nlm.nih.gov/pubmed/19862366
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!